Concepedia

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy

Nan Hee Kim, Jeong Heon Oh, Ji A Seo, Kye Won Lee, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Young Sun Kang, Sang Youb Han,

Kidney International · 2004 · 140 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 2002 · 10.4K citations

, , +11

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text

, , +17

VEGF is required for growth and survival in neonatal mice

Hans‐Peter Gerber, Kenneth J. Hillan, Anne Ryan et al. · Development · 1999 · 918 citations · Full text

, , +16

Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDR

Richard Kendall, Guan Wang, Kenneth A. Thomas · Biochemical and Biophysical Research Communications · 1996 · 727 citations

, , +8

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

Hikaru Sugimoto, Yuki Hamano, David M. Charytan et al. · Journal of Biological Chemistry · 2003 · 532 citations · Full text

, , +17